Logo of CARBOGEN AMCIS

CARBOGEN AMCIS

CARBOGEN AMCIS, a Dishman Carbogen Amcis Company, is a global development and manufacturing partner for complex medicines. Specialisms include high-potency APIs, linker and payload chemistry, precise bioconjugation for ADCs and clinical-to-commercial sterile fill-finish. Integrated analytics and CMC/regulatory capabilities reduce handoffs and accelerate timelines, while flow-enabled process design and engineered containment enhance control, throughput and safety at scale. Facilities across Europe and Asia support development, clinical supply and commercial manufacture.

Content by CARBOGEN AMCIS

A person in protective clothing in a biologics lab
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
A 3D rendering of red and yellow protein molecules floating in a fluid-like environment.
Discover approaches that shorten the path from DNA constructs to purified, functional proteins.
A 3D rendering of two DNA double helices in different colors, representing genetic diversity or molecular comparison on a light background.
By replacing conventional plasmid systems, cell-free DNA synthesis improves speed and quality in mRNA research.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue